IMO what is “obvious” is NOT that they don’t have
IMO what is “obvious” is NOT that they don’t have anything better to do or that their motivation stems from not liking the company or that it is personal. IMO what IS obvious is that they are paid by a well organized and well funded entity that’s goal for the past 6+ years has been to put IPIX out of business. The hard bashers are low IQ individuals that probably do work for peanuts. The soft bashers are much more skilled and specialize in nitpicking, creating Fear Uncertainty & Doubt (FUD) and creating false narratives. Many of them try to gain confidence from legit Longs by appearing to be pro-IPIX. They need to do this as they desperately need REAL shares to be sold. There are probably 6-8 individuals that post under 100+ aliases. Whether they are low level idiots, skilled soft bashers, affiliated trading crews; they are part of a bigger criminal element which makes them criminals. The one common trait they have is that they truly believe they are smarter than everyone else and that they do not leave behind a digital fingerprint. They ALWAYS eventually reveal themselves for what they are. They attempt to deflect attention away from what is actually taking place by for example blaming needed Aspire and MFO funding as the reason for IPIX share price (SP) decline rather than the obvious criminal activity of Naked Short Selling (NSS) and illegal Market Maker (MM) wash trade and share price manipulation with false volume due to a shortage of real shares being sold by real Longs . Moving up the criminal food chain is an entity (probably a hedge fund) that has been funding all of the above. They have been successful to date in compressing and controlling IPIX SP. The criminals have cost shareholders millions in savings and have severely delayed getting life saving drugs to market. The criminals have however underestimated IPIX determination and execution for advancing the science and have severely underestimated the patience and resolve of IPIX Longs.
IMO the next partnership deal will ignite a change in SP control. I believe B-OM and B-IBD pill form will be extremely lucrative and will greatly reward IPIX investors. If Kevetrin makes it to market it will further multiply shareholder wealth. The criminals will attempt to control SP as new demand forces their hand but they have dug themselves a very deep financial hole and IMO it will cause a reverse compression as their NSS or “air shares” become very expensive to cover. I am hopeful that the criminals get financially crushed and more importantly that they get brought to justice. I wonder how smart they will think they are when that happens?
16
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Top 5 Most Recently Viewed Articles
Exploring the Magnetic Force Microscope Market The magnetic force microscope (MFM) market is on a path of significant expansion, with predictions indicating growth from approximately USD 356 million to over USD 798 million over the next decade. This upward trend highlights a strong compound annual growth rate (CAGR) of 8.4%. The MFM is a vital tool in both industrial and...
Continue Reading
Brewing Trouble: Legal Storm for Black Rock Coffee Amid the aroma of freshly ground beans, Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) finds itself in a bitter brew of legal troubles. The steaming hot news is a securities class action lawsuit challenging the company's disclosures from its IPO. Investors who bought into the hype at $20 a share are now left with a lukewarm...
Continue Reading
Modaxo Expands Its Global Reach with New Acquisition Modaxo Inc. is a forward-thinking organization dedicated to enhancing the movement of people worldwide. Recently, the company has made strides in this mission by acquiring SISCOG - Sistemas Cognitivos, S.A., a well-respected provider of planning and scheduling technology solutions in the rail sector. This acquisition...
Continue Reading
Greater Washington Oral and Maxillofacial Surgery Opens New Office Greater Washington Oral and Maxillofacial Surgery is excited to announce the launch of its newest office in Stafford, Virginia. This strategic expansion underscores the practice's commitment to providing advanced oral surgical care and enhancing patient access in the region. A Commitment to Community and...
Continue Reading
Goldman Sachs Downgrades Pluxee France In a significant market shift, Goldman Sachs has announced a downgrade for Pluxee France SA (PLX: FP), moving its rating from Neutral to Sell. This decision demonstrates the firm's critical analysis of Pluxee's stock performance and its overall market position. Revised Price Target Alongside the downgrade, Goldman Sachs has adjusted...
Continue Reading
